Restatement of Previously Issued Consolidated Financial Statements (Tables)

12 Months Ended

Dec. 31, 2021

Restatement of Previously Issued Consolidated Financial Statements [Abstract]

Error Corrections in Consolidated Financial Statements

As of December 31, 2021

Consolidated Balance Sheets:

	Amount Previosly Reported		Amount As Restated
Income taxes payable	$	114,000	$	414,000
Total liabilities	$	361,000	$	660,000
Total equity	$	3,327,000	$	3,028,000

Year ended December 31, 2021

Consolidated Statements of Operations:

	Amount Previosly Reported			Amount As Restated
Income tax provision	$	120,000		$	420,000
Net loss	$	674,000		$	973,000
Net loss attributable to noncontrolling interest	$	47,000		$	92,000
Net loss attributable to U.S. Neurosurgical Holdings, Inc.	$	627,000		$	881,000
Basic and diluted net loss per share attributable to U.S. NeuroSurgical Holdings, Inc.	$	(0.08	)	$	(0.11	)